EPN 0.00% 2.4¢ epsilon healthcare limited

Current Price, page-380

  1. 593 Posts.
    lightbulb Created with Sketch. 45
    It’s true we are ahead, but a company is mainly evaluated by how much money they make, the sales and revenue growth. Although Manu license will be huge, we are a couple of years behind a serious revenue.
    This requires easing of regulation, I remember they had about $800 of revenue from selling medicinal cannabis.
    Right now, we are stuck because of regulations and the ODC. Even if we had all the licenses, there are only about 750 patients registered for special access, I am not sure how many times we can sell to them and how much that would mean in real profit terms.
    Besides all of this, there is competition.
    If we want to see major price growth, we need regulation change, otherwise I think all of the cannabis companies will go bankrupt in Australia.
    I think some people make a lot of money trading this stuck.
    The longer we wait for the license, the less effect it will have on the price.
 
watchlist Created with Sketch. Add EPN (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.